A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

NCT01279057 PHASE3 COMPLETED Results posted

This study compared the safety and efficacy of a generic fluticasone furoate (Lek Pharmaceuticals) nasal spray to the reference listed drug in the treatment of seasonal allergic rhinitis. Additionally both the test and the reference formulations were tested for superiority against a placebo nasal spray.

Details

Lead sponsor	Sandoz
Phase	PHASE3
Status	COMPLETED
Enrolment	727
Start date	Mon Dec 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Rhinitis, Allergic, Seasonal

Interventions

• Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals)
• Fluticasone furoate (Veramyst®) 27.5 mcg/actuation nasal spray
• Placebo

Countries

United States